Search

everythinglearnresearchcommunity

for

Search:↓

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

XEDAR triggers a specific signaling pathway in cells.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Hair shedding that lasts more than 6 months may need medical tests, but often just reassurance is enough.

Touching cats can increase the risk of getting a fungal scalp infection, especially in boys and kids over 5.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Testosterone's effects on COVID-19 are unclear and need more research.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

AGA linked to worse COVID-19 outcomes in men.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Adult mice with CBS deficiency show minimal health issues and normal lifespan despite high homocysteine levels.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.